Gengigel

Ricerfarma is an Italian pharmaceutical company specializing in the development and patenting of innovative products for oral health, dermatology, and gynecology. The company is best known for its flagship brand, Gengigel, a range of topical treatments based on high-molecular-weight hyaluronic acid produced through a specialized biotechnological process. Gengigel is designed to manage inflammatory and traumatic conditions of the oral mucosa, such as gingivitis and periodontitis, by mimicking the natural hyaluronan found in healthy gingival tissue to promote healing and provide a protective barrier. Ricerfarma operates primarily through an international licensing and distribution model, with its products available in over 80 countries worldwide. Their portfolio includes various formulations such as gels, sprays, and mouthwashes tailored for both professional dental applications and consumer home care.